Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/06/2005US6941229 Method of designing agonists and antagonists to EGF receptor family
09/06/2005US6939959 Efficient protein expression system
09/06/2005US6939958 can be used to express heterologous genes of interest within aleurone cells of a plant; cultures and transgenic plants; hybridizing nucleotide sequence
09/06/2005US6939957 corresponding proteins with recombinant plasmids bearing the nucleotide sequences in Escherichia coli; nucleocapsid (NP) protein and phosphoprotein (P)
09/06/2005US6939955 Hematopoietic growth factor inducible neurokinin-1 gene
09/06/2005US6939953 Polypeptide for use in the treatment of infections, asthma, inflammation, allergies, diabebtes, nervous system, glomerulonephritis, arthritis, bowel defects, psoriasis, diabetes, obesity, atherosclerosis
09/06/2005US6939952 Purified and isolated protein zero related (PZR) polypeptide
09/06/2005US6939951 G protein coupled receptors solubilized in two successive detergents; alkylglycosides, glycoside, monosaccharides, disaccharides, alkylphosphorylcholines; production into native or active structure
09/06/2005US6939950 Nucleotide sequences coding binding protein; for use in the treatment of cattle suffering from coliform mastitis or other inflammatory defects
09/06/2005US6939949 Protein for use in diagnosis and treatment of cancer
09/06/2005US6939948 blocks the binding of an anti-GD2 antibody to a tumor cell expressing GD2 ganglioside; elicit an immune response against a tumor associated antigen that is not normally immunogenic
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/06/2005US6939853 Administering glucagon-like peptide 1 (GLP-1) compound and an effective amount of an antidyslipidemic drug for therapy of dyslipidemia
09/06/2005US6939851 Serine proteinase inhibitors
09/06/2005US6939850 Treatment of inflammatory diseases and/or diseases characterized by cell deaths, as well as cancers, autoimmune disorders, infections
09/06/2005US6939849 Recombinant PDGF A-chain homodimers and methods of use
09/06/2005US6939848 Crystals of the large ribosomal subunit
09/06/2005US6939714 Epithelial cell growth inhibitors
09/06/2005US6939711 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
09/06/2005US6939710 Genes encoding sulfate assimilation proteins
09/06/2005US6939707 Isolated nucleic acid molecules which encode GAGE genes and uses thereof
09/06/2005US6939700 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
09/06/2005US6939697 Isolating and purifying therapeutic polypeptide using undulating solid support comprising polyethersulphone
09/06/2005US6939695 Nucleotide sequences coding polypeptide for generating amino acids for use in animal and human foods, medicines and nutrients
09/06/2005US6939694 Nucleotide sequences which code for the citB gene
09/06/2005US6939690 Polynucleotides encoding motilin homologs
09/06/2005US6939689 site-directed mutagenesis; annealing
09/06/2005US6939680 Nucleotide sequences coding protein for use in the treatment and prevention of nervous system, dyskinesia, kidney, vascular, circadian rhythms and vision defects
09/06/2005US6939679 NADE binding proteins
09/06/2005US6939677 useful for detection, diagnosis, and treatment of breast cancer; Human milk fat globule ( HMFG)
09/06/2005US6939675 Extraction; use in identifying, diagnosing, monitoring, or evaluating cancer; gel electrophoresis, hybridization, blot analysis, liquid chromatography
09/06/2005US6939548 Clostridium (C.) vaccination; fusion proteins; antibiotic resistance
09/06/2005US6939545 Composition and method for treating inflammatory disorders
09/06/2005US6939544 Antibodies against mouse pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
09/06/2005US6939543 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/06/2005US6939539 present invention relates to an improved composition of copolymer-1 comprising copolymer-1 substantially free of species having a molecular weight of over 40 kilodaltons
09/06/2005US6939533 Non-invasive localization of a light-emitting conjugate in a mammal
09/06/2005CA2296064C Infectious vectors and clones of plants derived from the turnip mosaic virus (tumv)
09/06/2005CA2261041C Bacillus thuringiensis strains showing improved production of certain lepidopteran-toxic crystal proteins
09/06/2005CA2260769C Immunological process for detecting antibodies directed towards tissue transglutaminase (ttg), use of ttg for diagnostic purposes and therapy control, and oral pharmaceutical agent containing ttg
09/06/2005CA2250693C Compositions and methods for taxol biosynthesis
09/06/2005CA2160034C Gibbon ape leukemia virus-based retroviral vectors
09/06/2005CA2105652C Reducing wound scarring with antibodies to growth factors
09/03/2005CA2499190A1 New fluorescent genetic fragments and fish
09/03/2005CA2457303A1 Transductin-1 and transductin-2 and applications to hereditary deafness
09/02/2005WO2004073646A2 Treatment of pain through expression of opioid receptors
09/02/2005CA2555996A1 Treatment of pain through expression of opioid receptors
09/01/2005WO2005080990A2 Immune diagnostic assay to diagnose and monitor tuberculosis infection
09/01/2005WO2005080988A1 Binding proteins as biosensors
09/01/2005WO2005080985A2 Methods and compositions for detecting and treating autoimmune diseases
09/01/2005WO2005080939A2 Method and device for detecting feline immunodeficiency virus
09/01/2005WO2005080585A1 Highly active glycoproteins-process conditions and an efficient method for their production
09/01/2005WO2005080577A2 Method for modulating gibberellic acid-dependent processes in plants
09/01/2005WO2005080571A1 The usage of mad-box genes in fruit & seed development by regulating active gibberellin synthesis
09/01/2005WO2005080569A1 Polypeptides, polynucleotides encoding same, antibodies thereagainst and methods of using same for diagnosing and treating cancer and skeletal disorders
09/01/2005WO2005080564A1 Anti-human pca-1 antibody
09/01/2005WO2005080545A2 Method for the production of recombined proteins in eukaryontic host cells
09/01/2005WO2005080436A2 Antibodies that bind pote and uses thereof
09/01/2005WO2005080434A1 Anti-clusterin oligoclonal antibodies for diagnosis and prediction of the aggressiveness of tumours, diagnostic method and related kits
09/01/2005WO2005080427A1 Galanin receptors and brain injury
09/01/2005WO2005080426A2 Protein ligands for nkg2d and ul16 receptors and uses thereof
09/01/2005WO2005080425A2 Leucine rich repeat containing protein
09/01/2005WO2005080424A2 Peptide yy analogues
09/01/2005WO2005080423A1 Antifungal peptides
09/01/2005WO2005080422A1 Method for predicting de novo biomacromolecule crystallization conditions and for crystallization of the same
09/01/2005WO2005080421A1 Novel polygalacturonase inhibitor protein and its use
09/01/2005WO2005080420A2 Hyphal growth in fungi
09/01/2005WO2005080419A1 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof
09/01/2005WO2005080418A2 Multimerised hiv fusion inhibitors
09/01/2005WO2005080417A2 Recombinant viruses with heterologous envelope proteins
09/01/2005WO2005080416A1 Feline calicivirus vaccines
09/01/2005WO2005080415A1 Epstein-barr virus (ebv) peptides and method for diagnosis of ebv-associated disease
09/01/2005WO2005079879A1 Collagen gel and process for producing the same
09/01/2005WO2005079859A1 Target directional carrier
09/01/2005WO2005079844A2 Use for interleukin-33 (il33) and the il-33 receptor complex
09/01/2005WO2005079838A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
09/01/2005WO2005079837A1 Methods of modulating il-23 activity; related reagents
09/01/2005WO2005079830A1 Inhibitors of amyloid fibril formation and uses thereof
09/01/2005WO2005079755A2 Interleukin-13 antagonist powders, spray-dried particles, and methods
09/01/2005WO2005079566A2 Gene disruptions, compositions and methods relating thereto
09/01/2005WO2005079523A2 Novel teleost derived antimicrobal polypeptides
09/01/2005WO2005079434A2 Modulation of epidermal growth factor heterodimer activity
09/01/2005WO2005079343A2 Identification and characterization of multiple splice variants of the mu opioid receptor gene
09/01/2005WO2005079316A2 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
09/01/2005WO2005079315A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
09/01/2005WO2005079267A2 Methods for protein production
09/01/2005WO2005079232A2 A METHOD FOR THE PRODUCTION OF AN ERYTHROPOIETIN ANALOG-HUMAN IgG FUSION PROTEINS IN TRANSGENIC MAMMAL MILK
09/01/2005WO2005079168A2 A novel stay-green gene and method for preparing stay-green transgenic plants
09/01/2005WO2005079155A2 Photoreactive compound specifically binding to calcium binding proteins
09/01/2005WO2005066203A3 Targeted immunogens
09/01/2005WO2005065711A3 Mammalian receptor proteins; related reagents and methods
09/01/2005WO2005060350A8 Diastereomeric peptides useful as inhibitors of membrane protein assembly
09/01/2005WO2005059136A3 Dna-sequence and recombinant production of group 4 major allergens from cereals
09/01/2005WO2005058953A3 Ogh fusion polypeptides and therapeutic uses thereof
09/01/2005WO2005054290A3 Peptide hormones zalpha48 and zsig97
09/01/2005WO2005054283A3 Clp-protease as target for herbicides
09/01/2005WO2005052191A8 Compositions and methods for the diagnosis and treatment of tumor
09/01/2005WO2005044838A3 Cd4+ epitopes of bone morphogenetic proteins
09/01/2005WO2005041898A3 Blood substitutes
09/01/2005WO2005031001A3 Novel therapeutic targets in cancer